Our Top Pick for more speculative investors is a biopharmaceutical company that discovers, develops, and commercializes oral antivirals in areas of unmet medical needs in the United States, explains Bill Mathews, editor of The Cheap Investor.
The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.
The drug is in Phase III clinical trials....More>>>
Sometimes I discuss stocks which sit out of my comfort zone, simply because they have a few characteristics which could be of interest to any kind of investor but don’t necessarily fit my portfolio. For example a blue chip stock which has features of positive capital gains combined with interesting dividend. In this case I am talking about Accenture (NYSE:ACN). A little bit more than a year....More>>>
Retirement comes as a welcome relief for well-prepared couples: a chance to travel, adopt new hobbies, and (finally) sleep in. It’s easy to overlook logistical details amid the excitement of beginning a new phase, and timing is as logistical as it gets.
As most couples do, you’ve probably been referring to D-Day as an all-encompassing “when ‘we’ retire,”....More>>>
Yet another profit upgrade sent Fever-Tree Drinks Plc shares soaring in early London trading, propping up an already giddy valuation for the U.K. maker of premium tonic water and lemonade. Shore Capital analysts say that while they can see the growth opportunity, a price-to-earnings ratio o
Singapore's largest property developer, CapitaLand (OTCPK:CLLDY) (CATL.SI) had a pretty good 2017. Helped by improving conditions in Singapore and China, not to mention significant project openings, CapitaLand's local shares climbed 20% and the ADRs did even better.
A power outage hit the CES consumer electronics show in Las Vegas, dimming the lights in one of the main convention halls hosting demonstrations from the likes of LG Electronics Inc. and Samsung Electronics Co.
“There is an isolated power outage at the Las Vegas Convention Center. W